isatin has been researched along with Triple Negative Breast Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abdel-Aziz, HA; Almahli, H; El-Naggar, M; Elaasser, MM; Eldehna, WM; Elgez, A; Fares, M | 1 |
Abdel-Aziz, HA; Al-Ansary, GH; Al-Dhfyan, A; Almahli, H; Aly, MH; Eldehna, WM; Ghabbour, HA; Ismael, OE | 1 |
2 other study(ies) available for isatin and Triple Negative Breast Neoplasms
Article | Year |
---|---|
Novel Thiazolidinone/Thiazolo[3,2-
Topics: Antineoplastic Agents; bcl-2-Associated X Protein; Benzimidazoles; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Female; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds, 2-Ring; Humans; In Vitro Techniques; Isatin; MCF-7 Cells; Molecular Structure; Proto-Oncogene Proteins c-bcl-2; Structure-Activity Relationship; Triple Negative Breast Neoplasms | 2018 |
Synthesis and in vitro anti-proliferative activity of some novel isatins conjugated with quinazoline/phthalazine hydrazines against triple-negative breast cancer MDA-MB-231 cells as apoptosis-inducing agents.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Female; Humans; Hydrazines; In Vitro Techniques; Isatin; Phthalazines; Triple Negative Breast Neoplasms | 2017 |